Cytosolic phospholipase A2α–deficient mice are resistant to experimental autoimmune encephalomyelitis
Mice, Knockout
0303 health sciences
Encephalomyelitis, Autoimmune, Experimental
Group IV Phospholipases A2
Cell Differentiation
Th1 Cells
Interleukin-12
Article
Immunity, Innate
Phospholipases A
Immunophenotyping
3. Good health
Mice, Inbred C57BL
Mice
Myelin-Associated Glycoprotein
Phospholipases A2
03 medical and health sciences
Cytosol
Spinal Cord
Animals
Female
Myelin-Oligodendrocyte Glycoprotein
Myelin Proteins
DOI:
10.1084/jem.20050665
Publication Date:
2005-09-19T19:18:07Z
AUTHORS (15)
ABSTRACT
Experimental autoimmune encephalomyelitis (EAE), a Th1-mediated inflammatory disease of the central nervous system (CNS), is a model of human multiple sclerosis. Cytosolic phospholipase A2α (cPLA2α), which initiates production of prostaglandins, leukotrienes, and platelet-activating factor, is present in EAE lesions. Using myelin oligodendrocyte glycoprotein (MOG) immunization, as well as an adoptive transfer model, we showed that cPLA2α−/− mice are resistant to EAE. Histologic examination of the CNS from MOG-immunized mice revealed extensive inflammatory lesions in the cPLA2α+/− mice, whereas the lesions in cPLA2α−/− mice were reduced greatly or completely absent. MOG-specific T cells generated from WT mice induced less severe EAE in cPLA2α−/− mice compared with cPLA2α+/− mice, which indicates that cPLA2α plays a role in the effector phase of EAE. Additionally, MOG-specific T cells from cPLA2α−/− mice, transferred into WT mice, induced EAE with delayed onset and lower severity compared with EAE that was induced by control cells; this indicates that cPLA2α also plays a role in the induction phase of EAE. MOG-specific T cells from cPLA2α−/− mice were deficient in production of Th1-type cytokines. Consistent with this deficiency, in vivo administration of IL-12 rendered cPLA2α−/− mice susceptible to EAE. Our data indicate that cPLA2α plays an important role in EAE development and facilitates differentiation of T cells toward the Th1 phenotype.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (124)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....